To me, it seems so absurd that they have approved this medication for 5-year-olds when they say clearly that ‘https://www.tga.gov.au/periodic/covid-19-vaccine-weekly-safety-report-21-10-2021’.
We cannot let this happen!
Here are three points that stood out to me;
- We are carefully monitoring and reviewing reports of suspected myocarditis and/or pericarditis following the Comirnaty (Pfizer) and Spikevax (Moderna) vaccines, particularly in younger age groups.
- For Comirnaty (Pfizer), to 17 October 2021, we have received 312 reports of suspected myocarditis alone or in combination with pericarditis, and an additional 836 reports of suspected pericarditis alone. In the same period for Spikevax (Moderna), we have received 5 reports of suspected myocarditis and 28 reports of suspected pericarditis. These events can occur due to other causes, including common viral infections, so it is expected that not all cases are related to vaccination. Our analysis of cases likely to be myocarditis suggests reporting is more common in teenage boys after the second dose of the Pfizer vaccine (5.2 cases per 100,000 doses) compared to the rest of the general population after a first or second dose (0.8 per 100,000 doses). This has also been observed in other countries.
- We are also closely monitoring rare reports of blood clots with low blood platelets (also called thrombosis with thrombocytopenia syndrome or TTS) linked to Vaxzevria (AstraZeneca). In the last week, 4 additional reports of blood clots and low blood platelets have been assessed as probable TTS, bringing the total number of cases to 156.